LifeMD, Inc. — Director's Dealing 2023

Jun 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-06-05

Reporting Person: Velge Bertrand (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-05	Common Stock	P	10383	$2.1651	Acquired	10383	Indirect
2023-06-06	Common Stock	P	129117	$2.1794	Acquired	139500	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	916666	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.15 to $2.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.14 to $2.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.